The pharmacology of hallucinogens.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects; D013759:Dronabinol / Q000494:pharmacology; D005071:Evoked Potentials / Q000187:drug effects; D005829:Geniculate Bodies / Q000187:drug effects; D006168:Guinea Pigs; D006213:Hallucinogens / Q000494:pharmacology*; D000882:Haplorhini; D006801:Humans; D008032:Limbic System / Q000187:drug effects; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology; D008251:Macaca; D008635:Mescaline / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D011562:Psilocybin / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D012154:Reticular Formation / Q000187:drug effects; D012160:Retina / Q000187:drug effects; D011984:Sensory Receptor Cells / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D013268:Stimulation, Chemical; D013329:Structure-Activity Relationship; D013787:Thalamic Nuclei / Q000187:drug effects; D014796:Visual Perception / Q000187:drug effects
D006213:Hallucinogens; D010627:Phenethylamines; D011562:Psilocybin; D012701:Serotonin; D013759:Dronabinol; D008238:Lysergic Acid Diethylamide; D000661:Amphetamine; D008635:Mescaline